Table 1.
Preoperative demographic, laboratory data, and indications of surgery of studied patients (n = 45).
| Parameters | Group 1 | Group 2 | P value | Total |
|---|---|---|---|---|
| (AKI Group) | (non-AKI) | n= 45 | ||
| n= 27 | n= 18 | |||
| Age in years (Mean±SD) | 47.40±15.24 | 44.55±13.95 | 0.529∗ | 46.26±14.64 |
|
| ||||
| Sex: | ||||
| Male, n (%) | 16 (59.25%) | 7(38.9%) | 0.231∗∗∗ | 23 (51.1%) |
| Female, n (%) | 11(40.75%) | 11(61.1%) | 22 (48.9%) | |
|
| ||||
| DM, n (%) | 9(33.3%) | 6(33.3%) | 1∗∗∗ | 15 (33.3%) |
|
| ||||
| Duration of DM in years (Mean±SD) | 7.66±3.64 | 8.83±2.48 | 0.507∗ | 8.13±3.18 |
|
| ||||
| HTN, n (%) | 13(48.14%) | 7(38.8%) | 0.760∗∗∗ | 20 (44.4%) |
|
| ||||
| Duration of HTN in years (Mean±SD) | 5.73±4.15 | 5.40±4.16 | 0.867∗ | 5.61±4.05 |
|
| ||||
| Virology: | ||||
| HCV n (%) | 23(85.2%) | 12(66.7%) | 0.149∗∗∗ | 9 (20%) |
| HBV n (%) | 3(11.1%) | 6(33.3%) | 1 (2.2%) | |
| No HBV& HCV n (%) | 1(3.7%) | 0 | 35 (77.8%) | |
|
| ||||
| WBCs (106/L) (Mean±SD) | 7.61±2.47 | 7.52±2.34 | 0.903∗ | 7.58±2.39 |
|
| ||||
| Hb (gm/dL) (Mean±SD) | 12.39±1.32 | 11.99±1.58 | 0.366∗ | 12.23±1.42 |
|
| ||||
| PLT (106/L) (Mean±SD) | 286.51±85.98 | 298.44±97.88 | 0.668∗ | 291.28±90.03 |
|
| ||||
| HCO3 (mEq/L) (Mean±SD) | 22.79±2.07 | 22.51±2.10 | 0.662∗ | 22.68±2.06 |
|
| ||||
| Na (mEq/L) (Mean±SD) | 140.03±5.17 | 141.66±4.56 | 0.285∗ | 140.68±4.95 |
|
| ||||
| K (mEq/L) (Mean±SD) | 4.21±0.54 | 4.16±0.67 | 0.764∗ | 4.19±0.59 |
|
| ||||
| Preoperative diagnosis | ||||
| IHD | 12(44.45%) | 7(38.9%) | 19 (42.2%) | |
| Valvular HD | 11(40.75%) | 6(33.3%) | 17 (37.7%) | |
| Cong. HD | 3(11.1%) | 0 | 0.074∗∗∗ | 3 (6.6%) |
| IHD& valvular HD | 1(3.7%) | 5(27.8%) | 6 (13.3%) | |
∗P value was computed by t-test.
∗∗∗P value was computed by Chi Square test.